vimarsana.com

Page 4 - லீப்ஃப்ராக் ஆம்புலேட்டரி அறுவை சிகிச்சை மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Leapfrog Group Announces Changes for 2021 Leapfrog Surveys of Hospitals and Surgery Centers

The Leapfrog Group Announces Changes for 2021 Leapfrog Surveys of Hospitals and Surgery Centers New Questions on Ethical Billing Practices and Health Inequity, along with COVID-19-Related Rule Changes News provided by Share this article Share this article WASHINGTON, March 10, 2021 /PRNewswire/ The Leapfrog Group, a national watchdog organization of employers and other purchasers focused on health care safety and quality, published changes to the 2021 Leapfrog Hospital Survey and Leapfrog Ambulatory Surgery Center (ASC) Survey. Leapfrog has added two new sets of questions in 2021 to assess whether hospitals and surgery centers practice ethical billing and track and address disparities in care that affect patient care. Leapfrog s employer constituency and multiple other stakeholders, along with compelling research, highlights the importance of ethical billing practices and attention to health inequity as important to patient outcomes.

Patient Safety Watchdog The Leapfrog Group Funded for National Initiative on Preventing Harm from Diagnostic Error

Patient Safety Watchdog The Leapfrog Group Funded for National Initiative on Preventing Harm from Diagnostic Error News provided by Share this article Share this article WASHINGTON, Jan. 28, 2021 /PRNewswire/ The Leapfrog Group, a national watchdog organization of employers and other purchasers focused on patient safety and quality, today announced Recognizing Excellence in Diagnosis , a new national initiative to publicly report and recognize hospitals for preventing patient harm due to diagnostic errors. Developed in collaboration with The Society to Improve Diagnosis in Medicine (SIDM) and key experts, the project is funded with a two-year grant of $1.2 million by the Gordon and Betty Moore Foundation.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.